It's a problem of limited resource allocation. The _point_ is that we have limited tests, so given limited supply why are we wasting the tests on those we think are sick. The limited supply could still be directed towards asymptomatic carriers. Wouldn't be testing everyone we want, but it's still more valuable than the allocation of tests right now.